Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients

Clinical and Investigative Medicine

Volumn 21, Issue 3, 1998, Pages 142-150

  McClennen, William ^a   Wilson, Thomas ^b  

^a Astra Canada   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FELODIPINE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; UREA;

ADULT; AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CANADA; CLINICAL CHEMISTRY; CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CREATININE BLOOD LEVEL; DIURETIC THERAPY; DOUBLE BLIND PROCEDURE; EDEMA; ELDERLY CARE; ELECTROCARDIOGRAM; FEMALE; FEVER; GENERAL PRACTICE; HEADACHE; HEART RATE; HOT FLUSH; HUMAN; HYPOKALEMIA; INFECTION; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; PAIN; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; PURPURA; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SIDE EFFECT; SINGLE BLIND PROCEDURE; SUSTAINED RELEASE PREPARATION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; UREA NITROGEN BLOOD LEVEL; VERTIGO;

AGED; AGED, 80 AND OVER; DELAYED-ACTION PREPARATIONS; DIURETICS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FELODIPINE; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; POSTMENOPAUSE; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; SODIUM CHLORIDE SYMPORTER INHIBITORS; SYSTOLE; TRIAMTERENE; VASODILATOR AGENTS;

EID: 0031746992     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-5.
2. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64.
3. MRC Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 1992;304:405-12.
4. Tweddel AC, Johnsson G, Pringle TH, Murray RG, Hutton I. The systemic and haemodynamic effects of felodipine in patients with coronary heart disease. Eur Heart J 1983;4:699-705.
5. Timmis AD, Campbell S, Monaghan MJ, Walker L, Jewitt DE. Acute haemodynamic and metabolic effects of felodipine in congestive heart failure. Br Heart J 1984;51:445-51.
6. Patel KR, Peers E. Felodipine, a new calcium antagonist, modifies exercise-induced asthma. Am Rev Respir Dis 1988;138:54-6.
7. Capewell S, Collier A, Matthews D, et al. A trial of the calcium antagonist felodipine in hypertensive type II diabetic patients. Diabetic Med 1989;6:809-12.
8. Carruthers SG, Larochelle P, Haynes RB, Petrasovits A, Schiffrin EL. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ 1993;149:289-93.
9. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
10. Shekelle RB, Ostfeld AM, Klawans HL. Hypertension and risk of stroke in an elderly population. Stroke 1974;5:71-5.
11. Stamler J, Neaton JD, Wentworth D. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989;13(Suppl I):2-12.
12. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation 1993;88:2460-70.
13. Messerli FH, Ventura HO, Amodeo C. Osler's maneuver and pseudohypertension. N Engl J Med 1985; 312:1548-51.